126-27-2,MFCD00079202
Catalog No.:AA000QLB

126-27-2 | Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
95%
in stock  
$299.00   $209.00
- +
100mg
95%
in stock  
$436.00   $305.00
- +
200mg
95%
in stock  
$656.00   $459.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA000QLB
Chemical Name:
Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl-
CAS Number:
126-27-2
Molecular Formula:
C28H41N3O3
Molecular Weight:
467.6434
MDL Number:
MFCD00079202
SMILES:
OCCN(CC(=O)N(C(Cc1ccccc1)(C)C)C)CC(=O)N(C(Cc1ccccc1)(C)C)C
NSC Number:
758444
Properties
Properties
 
Form:
Solid  
MP:
100 - 102°C  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
585  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
34  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
12  
XLogP3:
3.8  

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Confirming urinary excretion of mephentermine and phentermine following the ingestion of oxethazaine by gas chromatography-mass spectrometry analysis.

Journal: Journal of analytical toxicology 20100301

Title: Oxethazaine as the source of mephentermine and phentermine in athlete's urine.

Journal: Forensic science international 20090310

Title: Drug use in children: cohort study in three European countries.

Journal: BMJ (Clinical research ed.) 20080101

Title: Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20070401

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Intrahepatic flow disturbance: possibility of a hidden cause of drug toxicity.

Journal: Journal of pharmacological sciences 20060301

Title: Mechanisms involved in the contraction of intrahepatic portal vein branches by clomipramine and oxethazaine in isolated perfused rat livers.

Journal: Journal of pharmacological sciences 20050601

Title: [Clinical study on the pharmacological treatment of hemorrhoids with 0.25% oxethacaine chlorhydrate].

Journal: La Clinica terapeutica 20041001

Title: Biphasic effects of oxethazaine, a topical anesthetic, on the intracellular Ca(2+) concentration of PC12 cells.

Journal: Biochemical pharmacology 20020815

Title: [[Separation of oxetacaine and its metabolites] ].

Journal: Die Pharmazie 20010101

Title: SEIFTER J, ET AL. Oxethazaine and related congeners: a series of highly potent local anesthetics. Proc Soc Exp Biol Med. 1962 Mar;109:664-8.

Title: Soo-Yeun Lee, et al. The abuse potential of oxethazaine: Effects of oxethazaine on drug-seeking behavior and analysis of its metabolites in plasma and hair in animal models. Pharmacology, Biochemistry and Behavior

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:126-27-2 Molecular Formula|126-27-2 MDL|126-27-2 SMILES|126-27-2 Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl-
Catalog No.: AA000QLB
126-27-2,MFCD00079202
126-27-2 | Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl-
Pack Size: 50mg
Purity: 95%
in stock
$299.00 $209.00
Pack Size: 100mg
Purity: 95%
in stock
$436.00 $305.00
Pack Size: 200mg
Purity: 95%
in stock
$656.00 $459.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA000QLB
Chemical Name: Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl-
CAS Number: 126-27-2
Molecular Formula: C28H41N3O3
Molecular Weight: 467.6434
MDL Number: MFCD00079202
SMILES: OCCN(CC(=O)N(C(Cc1ccccc1)(C)C)C)CC(=O)N(C(Cc1ccccc1)(C)C)C
NSC Number: 758444
Properties
Form: Solid  
MP: 100 - 102°C  
Storage: Keep in dry area;Room Temperature;  
Complexity: 585  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 34  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 1  
Rotatable Bond Count: 12  
XLogP3: 3.8  
Literature fold

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Confirming urinary excretion of mephentermine and phentermine following the ingestion of oxethazaine by gas chromatography-mass spectrometry analysis.

Journal: Journal of analytical toxicology20100301

Title: Oxethazaine as the source of mephentermine and phentermine in athlete's urine.

Journal: Forensic science international20090310

Title: Drug use in children: cohort study in three European countries.

Journal: BMJ (Clinical research ed.)20080101

Title: Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer20070401

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Intrahepatic flow disturbance: possibility of a hidden cause of drug toxicity.

Journal: Journal of pharmacological sciences20060301

Title: Mechanisms involved in the contraction of intrahepatic portal vein branches by clomipramine and oxethazaine in isolated perfused rat livers.

Journal: Journal of pharmacological sciences20050601

Title: [Clinical study on the pharmacological treatment of hemorrhoids with 0.25% oxethacaine chlorhydrate].

Journal: La Clinica terapeutica20041001

Title: Biphasic effects of oxethazaine, a topical anesthetic, on the intracellular Ca(2+) concentration of PC12 cells.

Journal: Biochemical pharmacology20020815

Title: [[Separation of oxetacaine and its metabolites] ].

Journal: Die Pharmazie20010101

Title: SEIFTER J, ET AL. Oxethazaine and related congeners: a series of highly potent local anesthetics. Proc Soc Exp Biol Med. 1962 Mar;109:664-8.

Title: Soo-Yeun Lee, et al. The abuse potential of oxethazaine: Effects of oxethazaine on drug-seeking behavior and analysis of its metabolites in plasma and hair in animal models. Pharmacology, Biochemistry and Behavior

Building Blocks More >
1260667-05-7
1260667-05-7
3-Cyclopropylmorpholine
AA000QXC | MFCD18250298
1260874-83-6
1260874-83-6
1-(2-Cyanophenyl)azetidine-3-carboxylic acid
AA000REU | MFCD11037391
1261560-31-9
1261560-31-9
3-Methyl-4-(4-trifluoromethoxyphenyl)benzoic acid
AA000RR9 | MFCD18322427
1261892-14-1
1261892-14-1
2-Chloro-4-(4-fluoro-3-methoxyphenyl)benzoic acid
AA000S05 | MFCD18320679
1261941-65-4
1261941-65-4
2-(3-Pyrrolidinocarbonylphenyl)benzoic acid
AA000S47 | MFCD18312741
1261977-27-8
1261977-27-8
3-(5-Carboxy-2-fluorophenyl)benzoic acid
AA000S8A | MFCD18312666
126325-54-0
126325-54-0
3,5-Dibromo-2-methylpyridin-4-amine
AA000SHM | MFCD06797195
126541-81-9
126541-81-9
Methyl 3-nitro-4-trifluoromethylbenzoate
AA000STU | MFCD09264510
1268340-93-7
1268340-93-7
(Piperidinium-1-ylmethyl)trifluoroborate
AA000T85 | MFCD18071160
129799-14-0
129799-14-0
4-Benzyl 1-tert-butyl 2-methyl piperazine-1,2,4-tricarboxylate
AA000TMA | MFCD09038774
Submit
© 2017 AA BLOCKS, INC. All rights reserved.